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Abstract
Although the interiors of membrane and water-soluble proteins are similar in their physicochemical
properties, membrane proteins differ in having larger fractions of hydrophobic residues on their exteriors.
Thus, it should be possible to water-solubilize membrane proteins by mutating their lipid-contacting side
chains to more polar groups. Here, a computational approach was used to generate water-soluble variants of
the potassium channel KcsA. As a probe of the correctness of the fold, the proteins contain an agitoxin2
binding site from a mammalian homologue of the channel. The resulting proteins express in high yield
inEscherichia coli and share the intended functional and structural properties with KcsA, including secondary
structure, tetrameric quaternary structure, and tight specific binding to both agitoxin2 and a small molecule
channel blocker.
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Although the interiors of membrane and water-soluble proteins
are similar in their physicochemical properties, membrane pro-
teins differ in having larger fractions of hydrophobic residues on
their exteriors. Thus, it should be possible to water-solubilize
membrane proteins by mutating their lipid-contacting side
chains to more polar groups. Here, a computational approach
was used to generate water-soluble variants of the potassium
channel KcsA. As a probe of the correctness of the fold, the
proteins contain an agitoxin2 binding site from a mammalian
homologue of the channel. The resulting proteins express in
high yield in Escherichia coli and share the intended functional
and structural properties with KcsA, including secondary struc-
ture, tetrameric quaternary structure, and tight specific binding
to both agitoxin2 and a small molecule channel blocker.
The 3D structures of tens of thousands of water-solubleproteins have been solved, but the structures of membrane-
soluble proteins have proven much more difficult to deter-
mine. The problems associated with membrane proteins in-
clude their limited levels of expression, low stability in
detergent-solubilized forms, and greater difficulty in obtaining
high-resolution diffraction quality crystals. Thus, we and
others have sought to develop a broadly applicable automated
strategy for the preparation of water-soluble mutants of
membrane proteins, which could be obtained in larger quan-
tities for a variety of high-resolution biophysical and drug
discovery studies. Initial work yielded good results for a simple
transmembrane coiled-coil (1–3), but attempts to design wa-
ter-soluble versions of larger proteins such as bacteriorhodop-
sin led to misfolded proteins with very limited solubility in
water (4). Here, we demonstrate the success of a previously
undescribed computational approach for the design of a
water-solubilized version of a bacterial ion channel with a
transplanted mammalian toxin-binding site. These findings
have fundamental implications concerning the stabilization of
membrane vs. water-soluble proteins (5) as well as practical
implications for the design of water-soluble analogues of a
variety of biologically interesting membrane proteins.
The structures of many membrane proteins are beginning to
appear, allowing one to infer features common to entire
families. In particular, the structures of bacterial ion channels
(6–12) have provided insight into their mammalian counter-
parts, and the structure of rhodopsin (13) has served as a
prototype for the entire family of seven-transmembrane
G protein-coupled receptors. It would be advantageous to use
what structural information is available for a given membrane
protein to obtain water-soluble versions that retain their
structure, oligomerization state, and essential ligand-binding
properties. As a target for such an effort, we have chosen the
bacterial KcsA potassium channel because of its available
structure (6, 12), its biochemical characterization, and the
interest in this family of channel proteins. Furthermore, the
external vestibule of the ion-conducting pore of KcsA has been
mutated to the corresponding residues in a mammalian chan-
nel (Q58A, T61S, and R64D) to allow binding of agitoxin2
(AgTx2), resulting in a protein (designated here as tKcsA) that
binds AgTx2 (14). This system extends multiple clearly defined
criteria for the successful design of a water-soluble version of
this protein, which should: (i) be expressed at high level in a
water-soluble form; (ii) show the correct helical secondary
structure; (iii) associate to form tetramers; (iv) bind AgTx2
with high affinity, specificity, and in the appropriate stoichi-
ometry; and (v) bind small molecule channel blockers such
as tetraethylammonium chloride (TEA). The designed
water-soluble variants of tKcsA are referred to as WSK-1, -2,
and -3.
Methods
Protein Design. A statistical entropy-based formalism has been
developed for identifying amino acid probabilities from a given
backbone structure (15, 16). This method takes as input a target
structure, in this case a high-resolution structure of KcsA
(Protein Data Bank ID code 1k4c), and energy functions that
quantify sequence–structure compatibility. The output is the set
of site-specific probabilities of the amino acids compatible with
the structure. The site-specific probabilities of the amino acids
and their discrete side chain conformational states (rotamers)
are determined by maximizing an effective entropy function
subject to simultaneous constraints on both the overall energy as
determined by an atom-based potential and the value of an
effective solvation score (‘‘environmental energy’’). In the cal-
culation, all 20 amino acids and up to 10 of their side chain
conformations [rotamer states (17)] were considered at each site
where mutations were permitted. This yields a total of 129
identity-rotamer states for each variable position. C4 subunit
symmetry was imposed, reducing the complexity (total number
of possible sequence–rotamer combinations) from 129140 to
12935 for the first of the recursive calculations discussed
below (18).
To quantify hydrophobicity and solvation effects, an environ-
mental potential is used (16), where the local C density about
each residue is used to quantify its degree of exposure to solvent.
The environmental energy for the entire protein (Eenv) and for
the buried residue sites (Eenvb) are constrained to the average
values of water-soluble proteins in the calculation (46.0 and
24.6). The identities of buried sites are constrained in these
calculations, and the decrease in Eenv (from 20 to 46) largely
results from the mutation of exposed hydrophobic residues to
more hydrophilic amino acids.
Nonbonded interactions involving the side chains are calcu-
lated by using the AMBER 3A force field (19) with a modified
hydrogen-bonding term (20) and a distance-dependent dielectric
constant (  4 r). To address unfolded states, a reference
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energy ref () for each amino acid is introduced into the energy
Ec to represent the effects of the denatured state. The energy is
calculated as a ‘‘free energy’’ of each amino acid in its N-acetyl-
N-methylamide derivative with averaging over multiple back-
bone and rotamer states. This averaging involves a sum over
possible rotamers and possible backbone configurations, approx-
imated by varying each of the backbone  and  angles in
increments of 10°. This crudely approximates an average over
extended unfolded states. The reference energies of each amino
acid may then be estimated by using
ref, refref1lnzref, refzrefG, ref
zref, ref 
,,k
exprefref, , rk,
where ref is the conformational energy in a particular con-
formation of the N-acetyl-N-methylamide derivative of the
amino acid, as determined by using the molecular potential.
Here ref  1kBT, where kB is Boltzmann’s constant and T is
a temperature appropriate for the conformation sampling of
side chain and backbone conformations (e.g., T  300 K).
Reference energies are expressed relative to Gly (16). In the
statistical formalism of Scads (statistical computationally as-
sisted design strategy), accompanying the interatomic poten-
tial energy is a corresponding effective temperature 1. The
probabilities used in sequence identification were determined
for   0.5 molkcal; at this value, we find the sequence
properties are robust with respect to slight variation in back-
bone structure (16).
WSK Expression and Purification. The gene encoding WSK-1 was
synthesized with Pfu polymerase by using three fragments. The
final WSK-1 fragment was cloned into the pET-24a() vector
(Novagen) at the NdeI and XhoI restriction sites, expressing no
tag. Mutants WSK-2 and -3 were generated by using
QuikChange (Stratagene). The WSK proteins were expressed
in BL21(DE3) cells (Novagen) in LB for 4 h after induction
with 1 mM isopropyl--D-thiogalactoside. Cells were har-
vested by centrifugation at 4°C and 3,450  g. Cell pellets were
lysed by French press at 1,500 psi in lysis buffer containing 10
mM Tris[hydroxymethyl]aminomethane hydrochloride, pH
7.0, and 1 mM EDTA. Cell extracts were loaded onto a 40-ml
Q Sepharose (Amersham Pharmacia Biosciences) column in
the lysis buffer and eluted with a step gradient of the lysis
buffer containing 0–500 mM KCl. Fractions containing WSK
were pooled, concentrated to 50 ml, and further purified by
reverse-phase HPLC on a Vydac (Hesperia, CA) C4 prepar-
ative column by using a linear gradient of water and acetoni-
trile containing 0.1% trif luoroacetic acid. Purity was verified
by analytical reverse-phase HPLC, matrix-assisted laser de-
sorption ionization time-of-f light mass spectrometry, and
4–12% Bis-Tris SDSPAGE gels. The molar extinction coef-
ficient (280nm  17,781 M1cm1) was determined by the
difference in absorbance of a sample in 0 and 6 M
guanidineHCl , by using the calculated extinction coefficient
at 280 nm as a starting point.
AgTx2 Synthesis and Purification. AgTx2 (4,097 Da) was chemically
synthesized as a C-terminal carboxyamide on a 0.25 mmol scale
by using an Applied Biosystems model 433A solid phase
peptide synthesizer (Perkin–Elmer) with standard f luorenyl-
methoxycarbonyl amino acid chemistry. The tripeptide gly-
gly-N-2,4-dinitrophenyl-Ala chromophore was coupled to the
N terminus of half of the resin. AgTx2 with 2,4-dinitrophenyl-
Ala (AgTx2-DNP) has a calculated 356nm  11,343 M1cm1,
and 280nm  4,520 M1cm1. Peptides were washed on the
resin with dimethylformamide and ether, cleaved for 3.5 h with
trif luoroacetic acidwaterethanedithioltriisopropylsilane
(94.52.52.51) volvolvolvol, and precipitated and washed
with cold ether. Purification proceeded by reverse-phase
HPLC by using a preparative C4 column (Vydac) and a linear
gradient of the appropriate buffers. AgTx2 required oxidative
refolding to attain the proper folded state after HPLC. A series
of redox buffers containing increasing proportions of oxidized
(GSSG) and reduced glutathione (GSH) were made. The
concentration of GSSG was determined by UVVis absor-
bance by using 282nm  273 M1cm1, whereas GSH was
monitored by titration with Elmans reagent, following absor-
bance at 412 nm. Optimal conditions were identical for both
labeled and unlabeled peptides, and the final reaction com-
ponents were determined to 125 M toxin in the presence of
air and 100% GSH (6 mM). The progress of the reaction was
followed by using analytical reverse-phase HPLC and com-
parison of the magnitude of the properly folded peak to the
misfolded peaks. Properly folded toxins were repurified by
reverse-phase HPLC and tested for function.
Solution Measurements. CD spectra were collected on an Aviv
62DS (Aviv Associates, Lakewood, NJ) spectropolarimeter, by
using a 1-mm path-length quartz cuvette, with protein at 44
M, in 20 mM potassium phosphate, pH 7.0100 mM KCl1
mM EDTA. For ultracentrifugation, samples were centrifuged
at 15,000 rpm in 20 mM potassium phosphate, pH 7.0100 mM
KCl1 mM EDTA by using a Beckman XL-I (Beckman
Coulter) analytical ultracentrifuge. Equilibrium dialysis to
determine the stoichiometry of toxin binding to WSK-3 was
performed by using 0.5 ml of centrifuge tubes and a dialysis
membrane with a 10-kDa molecular weight cutoff. After
reaching equilibrium, the concentrations of AgTx2-DNP and
WSK-3 were determined by absorbance at 356 and 280 nm,
respectively.
The extent of binding of AgTx2-DNP (10 M) to WSK-3 (10
M, tetramer) was assessed at various concentrations of TEA
and tetramethylammonium ion by ultracentrifugation at
16,385  g. Because we expected some salt dependence to the
binding interaction, we also measured the extent of binding in
the presence of the same concentrations of KCl. The fraction
of free AgTx2-DNP was determined from the absorbance at
360 nm at the top of the cell (at this speed, the WSK-3 is
essentially fully depleted, but the AgTx2-DNP has not signif-
icantly sedimented). The extent of binding, relative to the KCl
control, was plotted and the IC50 determined (Fig. 5). The
approximate Kdiss for binding to TEA is determined from
the relationship IC50  KTEA [fAgTx2-DNP]KAgTx2-DNP, where
fAgTx2-DNP is defined as the free AgTx2-DNP concentration,
and KTEA and KAgTx2-DNP are the dissociation constants for
WSK-3 with TEA and AgTx2-DNP respectively. This relation-
ship holds approximately for [fAgTx2-DNP]  KAgTx2-DNP, where
[fAgTx2-DNP]  5 M and KAgTx2-DNP 	 2 M (because tight
binding is observed in the equilibrium dialysis with 10 M total
toxin concentration).
Results and Discussion
Design of WSK. The side chains of the transmembrane helices of
tKcsA were stripped to the backbone and then rebuilt in
accordance with the requirements for function, stability, and
water solubility. We retained the pore-lining residues, the
extracellular loops, the intracellular region, and the residues
required for binding to AgTx2. Furthermore, we retained the
buried residues, leaving 35 membrane-exposed side chains
[40% accessible to a probe with a radius of 1.4 Å (21)] per
protomer as targets for design. These positions were chosen by
using the computational design algorithm scads.
A key input into these calculations is an environmental
energy, a database-derived quantification of solvation and
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hydrophobic effects (16). The value of this environmental
score for WT KcsA is 20, which is well outside the range
observed for soluble proteins of this size, due to the large
number of exposed hydrophobic residues. Thus in calculations
to determine water-soluble sequences, the environmental en-
ergy was constrained to the value expected for soluble proteins
of this size, 46 (Fig. 1).
Scads generates profiles describing the site-dependent prob-
abilities of the amino acids at each position allowed to mutate.
A unique sequence was selected from the computed proba-
bilities by using recursive calculations. The set of 35 exposed
residues was initially targeted for variation. The identities of
the remaining residues were fixed at WT, and their side chain
conformations were permitted to vary to accommodate mu-
tations (15, 16). A sequence was selected comprising the most
probable amino acids at each site with the exception of several
sites where alternate amino acids with appreciable probability
were selected: W26E and G43A were chosen for their favor-
able helical propensities (22, 23) and S44, S69, and V106 were
kept at WT. The WT amino acid was selected at 8 of the 35
sites. A second calculation was then performed. In the pres-
ence of the resulting designed sequence from the first iteration,
an additional eight exposed hydrophobic sites were targeted
for mutation. The WT was most probable at L36, V39, L40,
I60, and L105; hydrophobic residues were probable at F116,
and the WT was retained. The mutation V93E was most
probable, and the L24D mutation was selected over the more
probable W and F due to its greater polarity. At position 104,
Gly and Ala had comparable probabilities, and Ala was chosen
for its aqueous helix propensity. The resulting sequence was
compared to 47 aligned K channel sequences from eight
prokaryotic and eukaryotic organisms (BLAST, National Cen-
ter for Biotechnology Information database).
The resulting sequence (WSK-1) had 29 mutations relative
to tKcsA (Fig. 2). Preliminary studies discussed below indi-
cated that this soluble protein bound toxin but formed high-
order oligomers. The model of WSK-1 showed two exposed
hydrophobic patches in the redesigned transmembrane helices,
which might mediate aggregation. This problem was addressed
Fig. 1. Eenv (16) vs. chain length. Eenv quantifies solvation and hydrophobic
effects and has been parameterized by using a database of 500 soluble
proteins (small circles) (16). For each protein structure, Eenv¥i (ai, ra,i, 
C)
where for the ith residue ai, ra,i, and 
C are the amino acid, side chain
conformation, and local density of  carbons. Also shown is the Eenv for WT
KcsA (open circle) and the value Eenv that was used as a constraint in the
sequence calculations (black circle).
Fig. 2. Depiction of KcsA and WSK-3. Only the side chains of outer helices (22–71), inner helices (89 –124), and cytoplasmic and extracellular residues are
shown. Side chains are colored based on frequency of occurrence in the apolar section of the lipid bilayer beginning with most probable: AlaIleLeuVal
(dark green), GlyMetThr (light green), and ProSerTrpTyr (light blue). LysArgGln (dark blue), AspGlu (red). (a) KcsA. Solvent-exposed residues of
KcsA allowed to vary in the design are depicted along the inner and outer helices (light green, dark green). Also shown are the cytoplasmic and extracellular
residues, unchanged in our design. (b) KcsA structure with side chains of mutated residues removed. Extracellular and cytoplasmic residues held constant
from KcsA to WSK are rendered. Buried residues within the interior of the structure are not shown. (c) WSK-3. Sequences of KcsA and WSK-3 are also shown,
where colored residues were mutated, whereas those in black were not. Mutations to tKcsA are shown in a gray box [made by using PYMOL (DeLano Scientific,
San Carlos, CA).
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in a new round of computational design varying only these
exposed hydrophobic regions, resulting in WSK-2, which con-
tained the additional mutation L116R, and WSK-3, which
contained both L81R and L116R.
The WSK sequences result from the simultaneous imposi-
tion of effective energetic constraints on the solvation prop-
erties and the interatomic interactions of the f lexible amino
acid side chains. One might expect that simply mutating
exposed hydrophobic residues to polar or charged amino acids
might be sufficient to confer solubility, but such approaches
often yield misfolded proteins (4). The calculations provide
sequences with sterically consistent nontrivial patterning of
amino acid identities. Among the polar mutations that were
introduced, complementary charge interactions on the protein
surface are apparent (see Fig. 2). Although the overall goal is
to produce a water-soluble structure, it must also retain
sufficient hydrophobic interactions to drive protein folding in
an aqueous environment. Thus, some exposed hydrophobes
are retained, and one mutation actually yields increased
hydrophobic character (S102V). Others have noted the im-
portance of careful consideration of interactions between
surface residues in protein design (24).
Secondary and Quaternary Structure of WSK Variants. WSK variants
were expressed in high yield (20 mgml) and in soluble form
in Escherichia coli. The CD spectra of the purified proteins
were consistent with the expected secondary structure,
showing minima at 208 and 222 nm ([222]  –14,600
degcm2dmol1). The computed -helical content was 	50%
(25), in good agreement with the helical content of 60%
observed for KcsA (Protein Data Bank code 1k4c).
Size exclusion chromatography was used to determine the
aggregation state of WSK variants. WSK-1 eluted as three
peaks: one peak consistently eluted as a large aggregate in the
void volume, whereas the observed molecular weights of the
other two peaks were 10,600 and 50,100 Da (Fig. 3a), in good
agreement with the expected masses for the monomer (11,433
Da) and tetramer (45,732 Da), respectively. Preliminary ex-
periments (not shown) showed that both the tetramer and the
higher-order aggregate bound AgTx2 in the proper stoichiom-
etry, suggesting that the void volume peak might consist of
loosely associated but otherwise properly folded tetramers. To
test this possibility, the molecular weight distribution was
measured in the presence of 6 M urea, a concentration lower
than that required to unfold the protein (as determined from
the loss of secondary structure followed by CD spectroscopy).
Under this condition, only the tetrameric and monomeric
peaks were observed (Fig. 3b).
WSK-1, -2, and -3 contain progressively fewer apolar side
chains in the redesigned transmembrane helices; these mutants
also show a progressively smaller fraction of aggregated pro-
tein eluting in the void volume. Even in the absence of urea,
WSK-3 elutes primarily as a tetramer and shows only a small
peak near the position expected for a 12-mer, presumably a
trimer of tetramers (Fig. 3 c and d). Thus, iterative mutagenesis
guided by computation and experiment was able to minimize
the nonspecific aggregates of tetramers seen in WSK-1.
AgTx2 Binding. Size exclusion chromatography was used to
demonstrate that WSK-3 specifically bound to AgTx2. For
these experiments, we synthesized a variant of AgTx2 with
AgTx2-DNP at its N terminus, allowing the toxin to be detected
from its absorbance at 356 nm (356nm  11,340 M1cm1).
When AgTx2-DNP was chromatographed through the Super-
dex 200 column, it eluted as a monomer, but when incubated
with WSK variants (10 M, assuming a functional tetramer),
it coeluted with the tetrameric and higher-order aggregate
peaks of WSK-1, -2, and -3 (data not shown) in approximately
the expected molar ratio of one AgTx2-DNP for every four
molecules of WSK.
Equilibrium analytical ultracentrifugation confirmed the
selective association of WSK-3 with AgTx2-DNP (Fig. 4).
WSK-3 sedimented in a concentration-dependent manner, and
the traces are well defined by a monomer–tetramer–12-mer
equilibrium (Fig. 4a), as expected from size exclusion chro-
matography. Under the same conditions, AgTx2-DNP shows
little sedimentation, consistent with its monomeric molecular
weight (4,435 Da). When incubated with WSK-3, AgTx2-DNP
cosediments with the water-solubilized channel (Fig. 4b), as
determined by the DNP absorbance. At a mol ratio of one
AgTx2-DNP per WSK-3 tetramer (17 M), there was essen-
Fig. 3. Analytical gel filtration chromatography of WSK-1 (20 M), WSK-1
(20 M, 6 M Urea), WSK-2 (100 M), and WSK-3 (100 M) by using a 25-ml
Superdex 200 column (Amersham Pharmacia Biosciences) in 20 mM K2PO4,
pH 7.0100 mM KCl1 mM EDTA at 1 mlmin flow rate. The approximate
volumes of elution for the monomer (Mon), tetramer (Tet), 12-mer, and
high-order aggregate (Agg) are indicated. The column was calibrated by
using blue dextran, BSA (66 kDa), ovalbumin (43 kDa), and carbonic anhy-
drase (29 kDa).
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tially no free AgTx2-DNP (26), indicating that the dissociation
constant for binding was 	2 M (i.e., 10-fold tighter than the
total toxin concentration). By contrast, when AgTx2-DNP was
centrifuged in the presence of BSA (36 M), no association
was observed (Fig. 4c), demonstrating the specificity of the
AgTx2–WSK-3 interaction.
The stoichiometry of toxin binding was determined by
equilibrium dialysis by using two starting conditions: one with
equimolar AgTx2-DNP and WSK-3 tetramer (10 M), as well
as one with a 2-fold excess of AgTx2-DNP. In both experi-
ments, the ratio of AgTx2-DNP:WSK-3 monomer was 1:4
within experimental error (1:4.4 and 1:4.1, respectively). Con-
trol experiments showed no binding of AgTx2-DNP to either
BSA or carbonic anhydrase (Table 1).
TEA Competition. To determine whether small molecule channel
blockers also bind specifically to WSK-3, we measured the
ability of TEA to compete with AgTx2-DNP for binding to
WSK-3. This small molecule blocker has been shown to
compete with charybdotoxin (a homologue of AgTx2) for
binding to the extracellular opening of the pore (27). TEA
induces dissociation of AgTx2-DNP from WSK-3 in a concen-
tration-dependent manner, whereas the control tetramethyl-
ammonium ion [TMA, which does not bind to K channels
(28)] showed no significant concentration-dependent compe-
tition (Fig. 5). From the concentration of TEA required to
induce 50% total toxin dissociation, we calculate a Kdiss 	 80
mM for TEA (assuming a Kdiss 	 2 M for binding of
AgTx2-DNP). This value agrees well with the reported Kdiss of
3.2–22 mM (29) for the native channel. TEA binds to the outer
vestibule of the channel KcsA channel. The finding that TEA
binds to WSK-3 strongly suggests that this region of the protein
is properly folded. Although this finding alone does not
preclude the possibility of misfolding elsewhere in the protein,
the additional CD, size exclusion chromatography, and toxin-
binding data together suggest that the protein has a structure
similar to the WT channel.
Conclusion
WSK-3 has successfully recapitulated the target properties of
tKcsA, including its ability to bind a protein toxin and a small
molecule blocker. These findings should be of practical utility for
the design of water-soluble analogues of membrane proteins that
have proven difficult to obtain in large quantities for biophysical
studies or drug screening. The method requires only a medium-
resolution structure for computational modeling. Thus, it should
be possible to extend this work to other ion channels and G
protein-coupled receptor proteins (30) using homology models
as starting points.
Fig. 4. Equilibrium sedimentation analytical ultracentrifugation of WSK-3 and AgTx2-DNP. (a) 17 M WSK-3 monitored at 280 nm (o). Data were fit to
a monomer–tetramer–12-mer equilibrium by using a macro in IGOR-PRO (WaveMetrics, Lake Oswego, OR). (b) AgTx2-DNP (17 M) in the presence (red circle)
and absence (green circle) of 17 M WSK-3 tetramer, monitored at 360 nm to detect only the AgTx2-DNP. (c) Control with BSA (36 M) plus AgTx2-DNP
(17 M) monitored at 280 nm (blue square) to monitor the BSA, and at 360 nm (green square) to monitor AgTx2-DNP.
Table 1. Equilibrium dialysis of WSK-3 and AgTx2-DNP
Experiment
[Tox]
bound,
M Stoichiometry
WSK-3mon (40 M)  Tox (10 M) 9.0 [WSK-3][Tox]bound  4.4
WSK-3mon (40 M)  Tox (20 M) 9.7 [WSK-3][Tox]bound  4.1
BSA (20 M)  Tox (44 M) 0
CA (47 M)  Tox (23 M) 0
Initially, WSK-3 and AgTx2-DNP (Tox) are on side a, whereas buffer is on side
b. At equilibrium, the concentration of bound toxin is given by [Tox]bound 
[Tox]a  [Toxfree]a  [Tox]a  [Tox]b.
Fig. 5. The small-molecule blocker TEA competes with AgTx2-DNP for
binding to WSK-3. A competition curve for tetramethylammonium ion is
also shown.
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